PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97342314 |
Filing Date: 04/01/2022 |
|
|
SERIAL NUMBER | 97342314 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\973\423\97342314\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | OPDUALAG |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) | The mark consists of the term "OPDUALAG" with a curved line over it. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 777 x 323 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Bristol-Myers Squibb Company |
INTERNAL ADDRESS | 14th Floor |
*MAILING ADDRESS | 430 E. 29th Street |
*CITY | New York |
*STATE
(Required for U.S. applicants) | New York |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses) | 10016 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for human use for the treatment and prevention of cancer. |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 03/22/2022 |
FIRST USE IN COMMERCE DATE | At least as early as 03/22/2022 |
SPECIMEN FILE NAME(S) | \\TICRS\EXPORT18\IMAGEOUT 18\973\423\97342314\xml1 \ APP0003.JPG |
SPECIMEN DESCRIPTION | image of the product and product packaging bearing the mark. |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
ATTORNEY INFORMATION | |
NAME | Marilyn F. Kelly |
ATTORNEY DOCKET NUMBER | 00161292-US |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | BRISTOL-MYERS SQUIBB COMPANY |
INTERNAL ADDRESS | TRADEMARKS DEPT., MAILSTOP D4243 |
STREET | P.O. BOX 4000 |
CITY | PRINCETON |
STATE | New Jersey |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 08648-4000 |
EMAIL ADDRESS | uspto-tm@bms.com |
OTHER APPOINTED ATTORNEY | Xiomara Triana; Anca M. Marcu |
CORRESPONDENCE INFORMATION | |
NAME | Marilyn F. Kelly |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | uspto-tm@bms.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | karl.kauper@bms.com; Anca.Marcu@bms.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Anca Marcu/ |
SIGNATORY'S NAME | Anca M. Marcu |
SIGNATORY'S POSITION | Trademark Counsel, BMS, Pennsylvania Bar member |
DATE SIGNED | 04/01/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97342314 |
Filing Date: 04/01/2022 |
The applicant's current Correspondence Information: |
Marilyn F. Kelly |
PRIMARY EMAIL FOR CORRESPONDENCE:
uspto-tm@bms.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): karl.kauper@bms.com; Anca.Marcu@bms.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |